Rigosertib sodium
Catalog No. A21824
Rigosertib sodium (ON-01910 sodium) is a multi-kinase inhibitor and a selective anti-cancer agent, which induces apoptosis by inhibition the PI3K/Akt pathway, promotes the phosphorylation of histone H2AX and induces G2/M arrest in cell cycle.
Catalog Num | A21824 |
---|---|
M. Wt | 473.47 |
Formula | C21H24NNaO8S |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 592542-60-4 |
Synonyms | ON-01910 sodium, ON01910, ON 01910 |
SMILES | COC1=CC=C(C=C1NCC([O-])=O)CS(/C=C/C2=C(C=C(C=C2OC)OC)OC)(=O)=O.[(E)].[Na+] |
Rigosertib sodium (ON-01910 sodium) is a multi-kinase inhibitor and a selective anti-cancer agent, which induces apoptosis by inhibition the PI3K/Akt pathway, promotes the phosphorylation of histone H2AX and induces G2/M arrest in cell cycle.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 21.12 mL | 105.6 mL | 211.21 mL |
0.5 mM | 4.22 mL | 21.12 mL | 42.24 mL |
1 mM | 2.11 mL | 10.56 mL | 21.12 mL |
5 mM | 0.42 mL | 2.11 mL | 4.22 mL |
*The above data is based on the productmolecular weight 473.47. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.